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Background: Otitis media (OM) is a common childhood disease characterised by middle ear effusion and inflammation.
Susceptibility to recurrent acute OM and chronic OM with effusion is 40-70% heritable. Linkage studies provide evidence
for multiple putative OM susceptibility loci. This study attempts to replicate these linkages in a Western Australian (WA)
population, and to identify the etiological gene(s) in a replicated region.
Methods: Microsatellites were genotyped in 468 individuals from 101 multicase families (208 OM cases) from the WA
Family Study of OM (WAFSOM) and non-parametric linkage analysis carried out in ALLEGRO. Association mapping utilized
dense single nucleotide polymorphism (SNP) data extracted from Illumina 660 W-Quad analysis of 256 OM cases and
575 controls from the WA Pregnancy Cohort (Raine) Study. Logistic regression analysis was undertaken in ProbABEL.
RT-PCR was used to compare gene expression in paired adenoid and tonsil samples, and in epithelial and macrophage
cell lines. Comparative genomics methods were used to identify putative regulatory elements and transcription factor
binding sites potentially affected by associated SNPs.
Results: Evidence for linkage was observed at 10q26.3 (Zlr = 2.69; P = 0.0036; D10S1770) with borderline evidence for
linkage at 10q22.3 (Zlr = 1.64; P = 0.05; D10S206). No evidence for linkage was seen at 3p25.3, 17q12, or 19q13.43. Peak
association at 10q26.3 was in the intergenic region between TCERG1L and PPP2R2D (rs7922424; P = 9.47 × 10-6),
immediately under the peak of linkage. Independent associations were observed at DOCK1 (rs9418832; P = 7.48 × 10-5)
and ADAM12 (rs7902734; P = 8.04 × 10-4). RT-PCR analysis confirmed expression of all 4 genes in adenoid samples.
ADAM12, DOCK1 and PPP2R2D, but not TCERG1L, were expressed in respiratory epithelial and macrophage cell
lines. A significantly associated polymorphism (rs7087384) in strong LD with the top SNP (rs7922424; r2 = 0.97)
alters a transcription factor binding site (CREB/CREBP) in the intergenic region between TCERG1L and PPP2R2D.
Conclusions: OM linkage was replicated at 10q26.3. Whilst multiple genes could contribute to this linkage, the
weight of evidence supports PPP2R2D, a TGF-β/Activin/Nodal pathway modulator, as the more likely functional
candidate lying immediately under the linkage peak for OM susceptibility at chromosome 10q26.3.
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Otitis media (OM) is a common childhood disease char-
acterised by the presence of infection (acute otitis media;
AOM) or fluid (otitis media with effusion; OME) in the
middle ear cavity. Most children experience at least one
episode of AOM by 1 year of age with up to 40%
experiencing recurrent episodes of AOM (rAOM; ≥3
episodes of AOM in 6 months) or chronic episodes of
OME (COME; middle ear effusion (MEE) ≥3 months) in
childhood [1]. Recurrent disease can result in perforation
of the tympanic membrane and/or conductive hearing
loss, leading to deficits in language development and poor
educational outcomes. Treatment for recurrent disease
may include insertion of tympanostomy tubes. High
prevalence rates of OM result in substantial health care
related costs and significant childhood morbidity in
many countries [2].
The causal mechanisms that lead to recurrent disease
are poorly understood but familial clustering and high
heritability estimates point to a genetic component.
Using self-reported AOM history from 2,570 Norwegian
twin pairs, Kvaerner et al. [3] determined heritability
estimates of 0.45 in males and 0.74 in females. Two pro-
spective twin and triplet studies have confirmed these
estimates. Casselbrant et al. [4] reported heritability esti-
mates of 0.73 for time with MEE in the first two years of
life. Likewise, Rovers et al. [5] reported heritability esti-
mates of 0.49 at 2 years increasing to 0.71 at 4 years with
a concomitant decrease in shared environment estimates
from 0.41 at 2 years to 0.16 by 4 years of age. Overall
these epidemiological studies confirm that susceptibility
to OM has a substantial genetic component that
increases with age.
To date, there have been few studies undertaken to
pinpoint the genes involved. Two genome-wide linkage
scans using multi-case families of Caucasian origin have
identified specific regions of the genome harbouring
putative susceptibility genes. The first identified two re-
gions of linkage on chromosome 10q26.3 and 19q13.43,
and a further region on 3p25.3 after conditioning on the
linked regions, suggesting epistatic interactions [6]. The
second identified two different regions of linkage on
17q12 and 10q22.3 [7]. Whilst the region of 19q13.43
has since been refined [8], there has been no replication
of any of these regions in independent studies and the
causal genes underlying them have yet to be identified.
To determine whether these genomic regions are im-
portant in recurrent/severe OM in a Western Australian
population we have carried out linkage analysis using
families who contain at least two individuals diagnosed
with rAOM or chronic OME (COME) recruited to the
Western Australian Family Study of Otitis Media
(WAFSOM) [9]. To identify the putative disease sus-
ceptibility locus in the only region that replicated inthis population, association using SNPs was undertaken
in the Western Australian Pregnancy Cohort (Raine)
Study [10]. Functional and bioinformatic studies were
used to further clarify the putative etiological gene.
Methods
Sample collection and phenotype definition
Linkage studies utilised samples from the WAFSOM
where probands with a history of tympanostomy tube
insertion due to rAOM or COME were identified from
the records of collaborating ear, nose and throat (ENT)
specialists (HC and SV) as previously described [9]. Par-
ents and full siblings with a history of recurrent disease,
defined as ≥3 physician diagnosed episodes of AOM or
tympanostomy tube insertion for rAOM or COME, were
also invited to participate. No exclusion was made on
the basis of ethnicity or gender; 93.2% of the families in
the WAFSOM self-identified as Caucasian. Recruitment
to the WAFSOM was approved by the Human Ethics
Committee at Princess Margaret Hospital for Children
(PMH). Written, informed consents were obtained both
for participation in the study and for DNA collection
from all adults or from the parents of participants less
than 18 years of age. For linkage analysis family members
with no history of recurrent disease were classified as
unaffected whilst all others were classified as unknown.
A total of 101 multicase families (107 nuclear families; 208
affected individuals; 468 total individuals) with 2 to 4
affected individuals were included in the linkage analysis.
For association mapping, we utilised data from the
Western Australian Pregnancy Cohort (Raine) Study
(‘the Raine Study’), a longitudinal cohort of children
whose mothers were recruited during early pregnancy
[10]. For the purposes of this study, data collected from
clinical examinations and parental questionnaires com-
pleted each year at the (average) ages of one, two and
three years was used to define a phenotype for OM.
Children were defined as a case if clinical examination
in the first three years of life indicated presence of in-
flamed, retracted or scarred TM, MEE or tympanostomy
tubes in situ. Participants were also classified as a case
where parents’ yearly reports indicated ≥3 episodes of
AOM had occurred up to the age of 3 yrs; 35% of cases
qualified on the basis of yearly questionnaire criteria
alone. Children with no clinical or parental reported
history of OM by the age of 3 yrs were classified as
controls. Based on questionnaire data, 94% of the Raine
Study participants self-identified their ethnicity as Cau-
casian. We used a subset of 831 Raine Study participants
(256 cases and 575 controls) for whom both genome-wide
data from an Illumina 660 W Quad Beadchip and complete
epidemiological data for covariates were available [11]. Co-
variates included day care attendance at <3 years of age, al-
lergy diagnosed at <3 years of age, and non-exclusive
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significant risk factors for OM in the Raine Study co-
hort [11]. Recruitment to the Raine Study and all
follow-ups were approved by the Human Ethics Com-
mittee at King Edward Memorial Hospital and/or
PMH, with specific adult re-consent for DNA for those
individuals participating in this study.
DNA extraction
High molecular weight genomic DNA was extracted
from a 2 mL saliva sample using the Oragene technology
(DNA Genotek) as per manufacturer’s instructions for
the WAFSOM study. Extracted DNA was re-suspended
in TE buffer, quantified by spectrophotometry, and stored
at 50 ng/μl at -20C.
For the majority of Raine Study participants genomic
DNA (gDNA) was extracted from whole blood collected
at the 14- or 17-year follow-up via venipuncture utilising
4 mL K2EDTA vacuum tubes. Extraction of DNA from
whole blood was performed utilising Qiagen PureGene
chemistry. For a small subset of individuals (~5%), gDNA
was extracted from saliva using the Oragene technology
(DNA Genotek) as per manufacturer’s instructions. Sam-
ples were quantified using spectrophotometry, diluted to a
normalised concentration with reduced EDTA TE buffer
and stored at −80°C.
Marker selection
For linkage analysis a minimum of four microsatellite
markers [12] spanning each reported [6,7] region of linkage
were identified. Marker names and primer sequences are
provided in Additional file 1: Table S1. For 10q26.3,
19q13.43 and 3p25.3 the reported marker at the peak
of linkage [6] was chosen in addition to four flanking
markers. Association mapping across the 10q26.3 region
was undertaken in the Raine Study cohort by extracting
data for 10,185 SNPs (2,270 genotyped, 7,915 by impu-
tation [13]) from cleaned [14], imputed [13] Illumina
660 W-Quad Beadchip data for 831 individuals (256
cases and 575 controls).
Genotyping
Microsatellite PCRs were performed on WAFSOM
DNAs using 15 ng genomic DNA, 1X PCR buffer,
2.6 mM MgCl2, 0.45 mM dNTPs, 0.04 M betaine,
0.87 μM - 1.1 μM forward and reverse primers, and 0.25U
of AmpliTaq Polymerase. Cycling was performed using a
touchdown protocol [15]. Amplification products were
pooled, fragments resolved using an Applied Biosystems
3130xl Genetic Analyzer (Life Technologies, California)
and alleles assigned via GeneMapper v4.1. All microsa-
tellites were in Hardy-Weinberg equilibrium in genetic-
ally unrelated founders. Mendelian inconsistencies wereidentified using the Pedcheck software [16] and corrected
or removed prior to analysis.
Genotype data for the Raine Study was generated at
the Centre for Applied Genomics (Toronto, Canada)
using an Illumina 660 W Quad Beadchip (Illumina, San
Diego, California). Quality control (QC) and imputation
for the Raine Study has previously been described [17].
Briefly, QC checks were performed for individuals and
SNPs using PLINK [18]. Individuals were excluded based
on gender mismatch, low genotyping rate (<97%), related
to other participants or low level of heterozygosity. SNPs
were excluded on the basis of deviation from Hardy-
Weinberg Equilibrium (HWE P < 5.7 × 10-7), a genotype
call rate <95%, or minor allele frequency <1%. For the
chromosome 10q26.3 region, a total of 2,270 genotyped
SNPs passed QC checks. Imputation was performed using
MACH v1.0.16 with CEU samples from the HapMap
Phase2 (Build 36, release 22) used as a reference panel
and a default threshold of r2 > 0.3. After imputation,
10,185 SNPs (2,270 genotyped, 7,915 imputed) were
available for analysis.
Linkage and association analysis
For microsatellite markers single-point and multi-point
non-parametric linkage (NPL) analysis was carried out
using all 101 multicase families with the Sall scoring
function in the program ALLEGRO [19] with genetic
map distances obtained from the Rutgers Map v2 [12].
Conditional linkage analysis was also performed in
ALLEGRO using only families showing evidence for
linkage (Zlr >0) at a specified region.
Association mapping of the 10q26 region was performed
using ProbABEL [20] for 10,185 SNPs in the region
127 Mb to qter. Power approximations [21] estimated for
a disease prevalence of 0.4 show that the Raine Study
has 86% power to detect associations at an alpha level
of P = 1 × 10-5 with genotype relative risk (GRR) of 1.5
for SNPs with a MAF = 0.2 and 95% power at P = 1 × 10-4.
Analysis was initially performed adjusting for popula-
tion substructure (i.e. including the first two Principal
Components; PCs), and then repeated, where appropriate,
adjusting for PCs and independently associated covariates.
If a strict Bonferroni correction was applied then the
P-value required to correct for the number of SNPs ana-
lysed in the Raine Study data is P = 4.9 × 10-6 (P = 0.05/
10,185). However, this is likely to be highly conservative
due to the known presence of linkage disequilibrium (LD)
in this region (i.e. 629 LD blocks across this 10q26 region,
data not shown). Therefore, as this is a replicated linkage
region [6,7], a relaxed threshold of P < 10-3 was used to
identify SNPs/genes of interest for follow-up. Logistic
regression modelling for independent effects between
pairs of SNPs was undertaken in R version 2.15.0 [22], and
results presented as PLRT for the likelihood ratio test
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using LocusZoom [23] in which -log10(P values) were
graphed against their chromosomal location. Pairwise LD
patterns between all regional SNPs and the respective top
SNP were calculated using the HapMap CEU population.
Qualitative PCR expression
For qualitative RT-PCR, RNA was extracted from mono-
nuclear cells isolated from 12 paired adenoid and tonsil
samples collected with parent/guardian consent during
adenoidectomy and/or tonsillectomy using TRI Reagent
(Sigma-Aldrich) according to manufacturer’s instruc-
tions [24]. Ethical approval for this part of the study was
obtained from the Ethics Committee of PMH. RT-PCR
was also performed on two respiratory epithelial and
three macrophage cell lines with/without infection with
otopathogens. All reagents were from Life Technologies,
Australia unless otherwise stated. Adenocarcinomic alveo-
lar basal epithelial cells (A549) were cultured in DMEM,
10% fetal bovine serum (FBS), 2 mM L-glutamine and
100U/ml penicillin/100 μg/ml streptomycin. A pharyngeal
carcinoma epithelial cell line (Detroit 562) was grown in
MEM with Earle’s salts, 10% FBS, 2 mM L-glutamine, 1X
non-essential amino acids, 1 mM sodium pyruvate and
100U/ml penicillin/100 μg/ml streptomycin. Both the pro-
monocytic U937 and monocytic THP-1 cell lines were
grown in RPMI 1640, 10% FBS, 2 mM L-glutamine and
100U/ml penicillin/100 μg/ml streptomycin whilst the
MonoMac 6 (MM6) mature monocytic cell line addition-
ally required 1X non-essential amino acids and 9 μg/ml
OPI bovine insulin (Sigma-Aldrich).
Cell lines were stimulated in vitro in 6-well plates with
either non-typeable Haemophilus influenzae (NTHi) or
Streptoccocus pneumoniae (SP) at a multiplicity of infec-
tion of 10:1. Bacterial cultures were kindly provided by
Dr Lea-Ann Kirkham (School of Paediatrics and Child
Health, University of Western Australia, Perth). Bacteria
were streaked and incubated overnight at 37ºC/5% CO2
on agar plates (blood for SP and chocolate for NTHi). A
viable count of bacteria was performed prior to infection
using a Helber bacterial counting chamber with Thoma
ruling (ProScitech). At the 0 hr time-point, 1 ml of bac-
teria (1 × 108 cfu/ml), or 1 ml of media for control sam-
ples, was added to 1 × 107 cells. After one hour media
was replaced to remove non-adhered bacteria. Cells were
harvested at 0, 1, 3, 6, 12 and 24 hours using TRI
Reagent and RNA extracted accordingly.
A standardised 500 ng of extracted RNA was reverse
transcribed using the High Capacity cDNA Reverse
Transcription Kit (Life Technologies) as per manufac-
turer’s instructions. For each cell line an RT negative
reaction was used as a negative control. Primers were
designed across exon-exon boundaries for four candidate
genes (Additional file 1: Table S2) under the linkagepeak and for the OAZ1 housekeeping gene [25]. cDNA
was amplified using a touchdown PCR protocol [15] in a
volume of 11.5 μl consisting of 20 ng cDNA, a PCR
master mix containing 0.85X PCR buffer, 2.6 mM
MgCl2, 0.45 mM dNTPs, 0.04 M betaine and 0.25 units
of AmpliTaq Polymerase (Life Technologies) and 8.7 ng
primer. Products were visualised on a 1.5% agarose gel
stained with ethidium bromide.
In silico comparative genomics
The presence of conserved non-coding sequences (CNS),
which may harbor important regulatory elements, were ex-
amined across the TCERG1L and PPP2R2D genes (± 10 kb
flanking sequence) plus the intervening intergenic region.
Genomic sequences and associated annotation for human,
mouse and rat were exported from Ensembl (Genome
Reference Consortium Release 37, Ensembl Release 67)
in FASTA and General Feature File (GFF) format, re-
spectively. Global alignment of genomic sequences was
performed in Multi-LAGAN [26,27] and the annotated
alignment visualized in SynPlot [28]. CNS regions were
defined as regions with a nucleotide sequence conser-
vation level of ≥0.6 that had no associated annotation.
To search for putative transcription factor binding sites
(TFBS) at SNP locations we used AliBaba v2.1 [29], and
MatInspector v8.0.5 [30] with a matrix similarity par-
ameter >0.75. We also assessed selected polymorphisms
(± 1000 bp flanking sequence) to determine whether
they are located within a CpG island, defined using a
criteria of C/G content >50%, ratio of observed to expected
CpG >0.6 and length >200 bp. Repetitive elements were
firstly masked using RepeatMasker [31] following which
CpG islands were identified using CpGIsland Searcher [32]
and CpGPlot [33]. Pairwise LD between polymorphisms in
the Raine Study was calculated using Haploview 4.1 [34].
Results
Linkage analysis
Results of linkage analysis using the 101 multi-case fam-
ilies available in WAFSOM are presented in Table 1.
Multi-point (peak Zlr = 2.69; P = 0.0036 at D10S1770)
and single-point (Zlr = 2.27; P = 0.012 at D10S1770) NPL
analysis provided evidence for linkage between markers
at chromosome 10q26.3 and OM, contributed to by both
the rAOM and COME phenotypes (Table 2). Analysis of
Caucasian families alone did not reveal a substantial dif-
ference in single-point results at any region (data not
shown); therefore, all multi-case families were used in
subsequent analyses. Linkage analysis conditional on the
linkage at 10q26.3 provided no evidence of epistatic inter-
actions with 19q13.43 or 3p25.3 in this study population
(data not shown), as previously reported [6]. Borderline
evidence (multi-point Zlr = 1.65; nominal P = 0.05) for rep-
lication of linkage was also observed at 10q22.3 whilst no
Table 1 Results of multi-point and single-point non-parametric linkage analysis in the WAFSOM across chromosomal
regions previously [6,7] linked to OM
Marker name Genetic map location
(cM) Marshfield
Physical location
(Start; Mb) NCBI build 36
Single-point Zlr P value Multi-point Zlr P value Information content
Chromosome 3p25.3
D3S1304 22 6.89 0.00 0.500 −0.93 0.175 0.88
D3S3691 29 8.82 −0.24 0.405 −1.15 0.126 0.90
D3S1597 30 9.34 −0.76 0.225 −1.04 0.149 0.92
D3S1263 36 11.49 −0.22 0.412 −1.13 0.130 0.88
D3S1259a 37 12.07 −0.14 0.444 −0.87 0.192 0.76
Chromosome 10q22.3
D10S1730 99 78.60 1.56 0.060 1.48 0.070 0.87
D10S206 98 79.45 1.88 0.031 1.65 0.050 0.83
D10S1677 100 79.88 0.30 0.383 1.40 0.081 0.87
D10S201 102 80.69 1.71 0.044 1.46 0.072 0.86
Chromosome 10q26.3
D10S1655 162 130.85 1.52 0.065 1.65 0.050 0.85
D10S169 173 132.41 1.30 0.098 2.51 0.006 0.91
D10S1770 169 132.57 2.27 0.012 2.69 0.004 0.92
D10S212a 171 134.29 1.66 0.048 2.42 0.008 0.87
D10S1711 171 135.05 0.90 0.183 2.52 0.006 0.85
Chromosome 17q12
D17S1293 56 29.58 0.32 0.373 0.40 0.345 0.87
D17S933 58 30.22 0.36 0.361 0.28 0.391 0.84
D17S927 58 32.08 0.68 0.247 0.46 0.324 0.88
D17S946 60 34.11 1.63 0.052 1.09 0.137 0.84
Chromosome 19q13.43
D19S572 89 58.80 −0.23 0.409 −0.22 0.413 0.81
D19S210 100 61.71 0.01 0.500 −0.85 0.198 0.94
D19S887 100 62.33 −0.60 0.274 −0.13 0.447 0.96
D19S254 101 62.36 0.19 0.425 −0.22 0.414 0.95
D19S214a 101 62.47 −1.85 0.032 −0.44 0.330 0.95
aMarker at peak of linkage reported by Daly et al. [6].
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observed at 3p25.3, 17q12 or 19q13.43.
Association mapping of the 10q26.3 region in the Raine
Study cohort
In our study, the peak of linkage at 10q26.3 is observed
at 169 cM (Marshfield Genetic map)/132.57 Mb (NCBI
Build 36), with evidence for linkage extending proximally
to 130.85 Mb and distally to 135.05 Mb. Daly et al. [6]
report clear evidence for linkage only at microsatellite
marker D10S212, located at 171 cM/134.29 Mb, with
no evidence for linkage ~126 Mb (Table 3). Although
the disease locus in a linkage study might normally be
found immediately under the peak of linkage [35], the true
susceptibility gene can be displaced by up to 10 cM(~10 Mb) from the linkage peak, particularly in smaller
samples [36,37]. Therefore, we extended our search for
genes through association mapping over the region
127 Mb to 135.35 Mb (=qter).
For association mapping, genotype data from the region
127 Mb to 135.35 Mb on chromosome 10 was extracted
from Illumina 660 W-Quad BeadChip data in 831 indi-
viduals (256 cases and 575 controls) from The Raine
Study for whom full covariate data were available [11].
SNP locations on this Illumina chip are provided as
NCBI Build 36 base pair locations. Data were available
for 10,185 SNPs (2,270 genotyped, 7,915 by imputation).
Logistic regression analysis under an additive model, con-
trolling for population substructure using 2 PCs as covari-
ates, provided evidence for several regions of association
Table 2 Results of multi-point and single-point non-parametric linkage analysis in the WAFSOM for the 10q26.3 region




Multi-point Zlr P value Information content Multi-point Zlr P value Information content
D10S1655 1.83 0.034 0.84 1.23 0.110 0.89
D10S169 2.44 0.007 0.90 1.76 0.039 0.93
D10S1770 2.63 0.004 0.91 2.00 0.023 0.95
D10S212a 2.20 0.014 0.86 1.76 0.039 0.91
D10S1711 2.34 0.010 0.84 1.66 0.048 0.89
aMarker at peak of linkage reported by Daly et al. [6].
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grees of statistical support (Figure 1; Additional file 1:
Table S3). In summary, individual top SNPs within genes/
regions (P < 10-3) are: rs7902734 intronic in ADAM12 at
127.94 Mb (P = 8.04 × 10-4); rs9418832 intronic in DOCK1
at 128.76 Mb (P = 7.48 × 10-5); rs2996081 intronic in
TCERG1L at 132.86 Mb (P = 9.15 × 10-4) and rs7922424
intergenic between TCERG1L and PPP2R2D at 133.21 Mb
(P = 9.47 × 10-6). Association signals across these genes/
regions were robust to adjustment for independent envir-
onmental/clinical covariates (Additional file 1: Table S4).
Testing for independent effects in genes across the
chromosome 10q26 region
To evaluate whether the putative regions of association
across the 127 Mb to qter region on chromosome 10q26
represented independent signals we repeated the single-
point logistic regression analysis adjusting for the most
significantly associated SNP (i.e. rs7922424; Figure 2).
Upon adjusting for rs7922424 (Figure 2A), the signifi-
cance at neighbouring SNPs within this intergenic region
was lost indicating there is a single main effect across
the TCERG1L_PPP2R2D intergenic region. However, im-
proved significance was observed at DOCK1 (top SNP
rs9418832; P = 4.77 × 10-5), suggesting that these genes/
regions may be independently associated with OM. All
other signals were at P > 10-3 after adjusting for rs7922424.Table 3 Comparison of results from the WAFSOM linkage ana
Daly et al. [6]
Marker name Genetic map position
(cM) Marshfield
Physical location
(Start; Mb) build 36
Spt Zlr P
D10S1656 149 126.09 -
D10S217 158 129.54 -
D10S1655 162 130.85 1.52
D10S1248 171 130.98 -
D10S169 173 132.41 1.30
D10S1770 169 132.57 2.27
D10S212 171 134.29 1.66
D10S1711 171 135.05 0.90Given evidence of an independent effect at rs9418832
we also adjusted for this SNP (Figure 2B). When adjusting
for rs9418832 significance was lost across the DOCK1
region, again indicating a single main effect within this
region, whilst improved significance was observed at
rs7922424 (P = 6.47 × 10-6), ADAM12 (top SNP rs7902734;
P = 2.05 × 10-4) and TCERG1L (top SNP rs2996081;
P = 4.26 × 10-4). The most significant association after
adjusting for both rs7922424 and rs9418832 was observed
at rs7902734 in ADAM12 (Figure 2C; P = 4.52 × 10-4),
indicating that ADAM12 may also be independently
associated with OM.
To formally test for independent effects between
ADAM12, DOCK1 and the TCERG1L_PPP2R2D inter-
genic region, we used forward stepwise logistic regres-
sion modelling. When comparing models in which the
top SNPs are added to each of the other top SNPs (i.e.
alternative 2-SNP model compared to the null 1-SNP
model; Table 4) results show that they all add independent
effects to each other (PLRT ≤ 0.001). Comparison of models
containing all three SNPs compared to a null model con-
taining only 2 of the top SNPs confirms these SNPs all
add independent effects to each other (P ≤ 4.37 × 10-4).
Overall, the data suggest that variants in the intergenic
region between TCERG1L and PPP2R2D, which lies at
133.2 Mb directly under the peak of linkage (Table 3), as
well as in DOCK1 (128.8 Mb) and ADAM12 (127.9 Mb),lysis for chromosome 10q26 with those published by






- - - 0.0 0.0 OAT
- - - 0.2 0.2 DOCK1_FOX12
0.065 1.65 0.050 - - PTPRE_MGMT
- - - 0.0 0.4 MKI67_MGMT
0.098 2.51 0.006 - - GLRX3_TCERG1L
0.012 2.69 0.004 - - GLRX3_TCERG1L
0.048 2.42 0.008 3.78 1.64 INPP5A



































































Figure 1 LocusZoom plots of association for the region spanning 127 Mb to qter in the Raine study. Pairwise values of linkage disequilibrium
with the top SNP (rs7922424; in purple) were calculated using the HapMap CEU population. The top SNP in other genomic regions have been
labeled on the plot.
Rye et al. BMC Medical Genetics 2014, 15:18 Page 7 of 14
http://www.biomedcentral.com/1471-2350/15/18may contribute independently to susceptibility to OM.
Therefore, we took these genes/regions forward in
evaluating further evidence for the putative etiological
gene(s) for OM under the peak of linkage on chromo-
some 10q26.Expression analysis to support putative functional genes
Information on the expression pattern of several genes
in the 10q26 region is currently limited. Therefore, another
way to evaluate potential candidacy of disease associated




























Figure 2 LocusZoom plots of association adjusted for the top two SNPs, (A) rs7922424, (B) rs9418832 and (C) rs7922424 and rs9418832.
Significance is retained at each SNP after adjusting the analysis for the other. Pairwise values of linkage disequilibrium with the top SNP (in purple)
were calculated using the HapMap CEU population.
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Table 4 Likelihood ratio tests (LRT) to determine independent effects across the 10q26.3 region
Null model Alternative modela LRT χ2 PLRT-value
Adding ADAM12 SNP
DOCK1/rs9418832 rs9418832 + rs7902734 13.89 1.94 × 10-4
Intergenic/rs7922424 rs7922424 + rs7902734 9.88 0.0017
rs9418832 + rs7922424 rs9418832 + rs7922424 + rs7902734 12.37 4.37 × 10-4
Adding DOCK1 SNP
ADAM12/rs7902734 rs7902734 + rs9418832 18.12 2.07 × 10-5
Intergenic/rs7922424 rs7922424 + rs9418832 16.31 5.39 × 10-5
rs7902734 + rs7922424 rs7902734 + rs7922424 + rs9418832 18.80 1.45 × 10-5
Adding TCERG1L_PPP2R2D intergenic SNP
ADAM12/rs7902734 rs7902734 + rs7922424 17.92 2.31 × 10-5
DOCK1/rs9418832 rs9418832 + rs7922424 20.11 7.30 × 10-6
rs7902734 + rs9418832 rs7902734 + rs9418832 + rs7922424 18.60 1.61 × 10-5
amarker added to the null model in the alternative model is highlighted in bold.
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To address the former, we looked at expression of
genes in paired adenoid and tonsil tissue from OM
cases (rAOM, OME) compared to controls diagnosed
with obstructive sleep disorder (OSD) or recurrent acute
tonsillitis (RAT) with no concurrent OM history. The role
of adenoids in OM pathogenesis is supported by a sys-
tematic review showing that adenoidectomy significantly
improves resolution of MEE in OM [38] whereas tonsil-
lectomy alone does not [39]. Figure 3A summarises the
RT-PCR expression data across adenoid and tonsil sam-
ples and shows that ADAM12, DOCK1, TCERG1L and
PPP2R2D are, for the most part, expressed in all
adenoid samples irrespective of OM or OSD diagnosis.
In tonsil samples, ADAM12 and DOCK1 are again
expressed in all samples irrespective of diagnosis. How-
ever, TCERG1L and PPP2R2D expression is less consis-
tent in tonsils with at least two samples showing no
expression.
We also looked at epithelial (A549 & Detroit 562) and
macrophage (U937, THP-1 & MM6) cell lines (Figure 3B).
Again, ADAM12 and DOCK1 appear to be expressed in
all five cell lines whilst PPP2R2D was seen in all cell
lines except for MM6. Interestingly, TCERG1L was not
expressed in epithelial or macrophage cell lines. TCERG1L
expression was also not detected in any cell line follow-
ing bacterial challenge with two common otopathogens
(NTHi & SP; data not shown), suggesting that any role
for this gene in OM would be independent of macrophage
or epithelial cell inflammatory responses to otopathogens.
It should be noted that this expression data is only
qualitative. It is likely that quantitative RT-PCR data
would add further information regarding expression
levels at these candidates.In silico comparative genomics analysis of the TCERG1L
to PPP2R2D region
While statistical and expression analyses do not formally
exclude any of the genes showing association under the
chromosome 10q26 linkage peak with OM, the statis-
tical analyses favour the interval TCERG1L to PPP2R2D
(Additional file 2: Figure S1), which lies directly under
the peak of linkage for OM at chromosome 10q26, as
the most likely candidate region carrying the etiological
variants associated with OM susceptibility. Since the
peak of association lies in the intergenic region between
these two genes, we carried out an in silico analysis to
determine whether the associated SNPs in this region
lie in highly conserved non-coding sequences that could
contain regulatory elements (Additional file 2: Figure S2).
Of the 9 associated SNPs (P < 0.001) within the intergenic
TCERG1L to PPP2R2D interval, three are located within
highly conserved, non-coding regions (nucleotide con-
servation level (NCL) ≥ 0.6); rs7037834 (NCL = 0.61),
rs7914323 (NCL = 0.61) and rs11813611 (NCL = 0.67).
However, rs11813611 lies within a long interspersed nu-
cleotide element (LINEs) repeat region and is unlikely to
be functionally relevant. The top SNP, rs7922424, does
not lie in a conserved non-coding region but is in strong
LD with rs7087384 (r2 = 0.97) and rs7914323 (r2 = 1.00),
both of which do fall in conserved non-coding regions
(Additional file 2: Figure S3).
We also looked for the presence of transcription fac-
tor binding sites (TFBS) that may be co-located with
rs7922424 (top SNP), rs7087384 or rs7914232 (within
CNS regions). Results (Additional file 1: Table S5) indicate
that rs7922424 lies within the consensus sequence for the
Upstream Stimulatory Factor-1 (USF1) transcription factor
with the binding site abolished in the presence of the
Where rAOM = recurrent acute otitis media, OSD = obstructive sleep disorder, 
RAT = recurrent acute tonsillitis, OME = otitis media with effusion. 
(A)
(B)
Figure 3 RT-PCR expression of various candidate genes in (A) adenoids and tonsils of differing phenotypes and (B) in epithelial and
macrophage cell lines. OAZ1 is the housekeeping gene. A green diagonally striped box indicates expression was observed whilst a red dotted
box indicates no expression was observed.
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minor disease associated allele (T) at rs7914323 potentially
introduces a USF1 binding site. For rs7087384, the minor
disease associated (A) allele disrupts a putative CREB/
CREBP1 transcription factor binding site.
In addition to TFBS, we looked at the region contai-
ning rs7922424, rs7087384 and rs7914323 to determine
whether these SNPs fall in regions identified as a CpG
island and as such could disrupt biologically relevant
DNA methylation at CpG motifs. Results from CpG Plot
and CpG Island Searcher indicate that none of these
polymorphisms falls at or near a CpG island (data not
shown).
Discussion
Genome-wide linkage analyses have highlighted five
regions containing OM disease susceptibility loci on
chromosomes 3p25.3, 10q22.3, 10q26.3, 17q12, and
19q13.43 [6-8]. Here, using a Western Australian cohort
of children diagnosed with recurrent OM, we foundevidence of replication of linkage at 10q26.3. We also
found borderline evidence to support a region of linkage
at 10q22.3 but did not find evidence for linkage at
3p25.3, 17q12, or 19q13.43, or for any region after con-
ditioning on 10q26.3. Therefore, we focused attention
on mapping the genes under the chromosome 10q26.3
linkage peak.
To identify the etiological gene/variant under the
10q26.3 peak, we performed fine-mapping using directed
analysis of 2,270 genotyped SNPs (10,185 after imput-
ation) spanning this region available on 256 cases and
575 controls within the Raine Study cohort. We focused
our search in the region 127 Mb to qter, and found stat-
istical support for variants in several genes/regions
across this region contributing to the linkage peak. This
is not an unusual phenomenon in complex diseases,
where previous studies have also highlighted multiple
genes contributing to peaks of linkage [40]. In this case,
for the region of linkage at 10q26.3, at least 49 genes
lie within the interval, a number of which could be
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susceptibility. Statistical support was observed for inde-
pendent effects of SNPs at ADAM12, DOCK1 and the
intergenic region between TCERG1L and PPP2R2D.
The ADAM12 (A Disintegrin and Metalloproteinase do-
main 12) gene is a member of the disintegrin and metallo-
proteinase (ADAM) family of proteins. This gene has
been implicated in the epidermal growth factor receptor
(EGFR) signalling pathway [41], which is upregulated in
human middle ear epithelial cells in response to tobacco
smoke exposure [42]. The ADAM12 protein also interacts
with the muscle-specific α-actinin-2 protein, with function
centred on myoblast/muscle development showing in-
creased expression during muscle generation [43]. The
DOCK1 (Dedicator of cytokinesis 1) protein has roles in
phagocytosis of apoptotic cells in concert with ELMO1
during Rac signalling and cellular migration [44,45]. The
DOCK1 gene also has a role during embryogenesis in
muscle development with knock-out mouse mutants hav-
ing decreased skeletal and respiratory muscle tissues [46].
This suggests the apoptotic function of DOCK1 could
have a subtle role in the cell death of inflammatory factors
and in apoptosis of mucous cells after an immune re-
sponse to OM, whilst the ADAM12 protein interacts
with pathways that could influence expression of in-
flammatory mediators within the middle ear.
The strongest statistical support for association was in
the TCERG1L to PPP2R2D intergenic region, directly
below the peak of linkage on chromosome 10q26.3. Very
little is known about the function of the transcription
elongation regulator like protein (TCERG1L) gene. In re-
cent GWAS studies, variants at or near TCERG1L have
been associated with fasting insulin, insulin resistance
[47] and attention deficit disorder [48]. Hypermethyla-
tion of the TCERG1L promoter region leading to gene
silencing has also been observed in colon cancer [49].
TCERG1L expression is documented [50] in a variety of
tissues, including the brain, lung and eye. In this study,
we have also demonstrated that TCERG1L is expressed
in adenoids but not in macrophage or epithelial cell
lines, either with or without otopathogen infection.
Whilst expression in these cells may have been downreg-
ulated during immortalization, analogous to downregu-
lation of this gene in cancer cells [49], the data suggest
that any role TCERG1L may play in OM susceptibility
is unlikely to occur through the innate inflammatory
response to otopathogens. On balance, TCERG1L does not
appear to be a strong candidate for OM susceptibility.
In contrast, PPP2R2D is a particularly interesting can-
didate gene for OM. PPP2R2D is a member of the B
family of regulatory subunits of the protein phosphatase
2A (PP2A) and is widely expressed at the protein level
in the brain, heart, placenta, skeletal muscle, testis and
thymus [51]. This protein has a role as a modulator ofthe TGF-β/Activin/Nodal pathway [52], where knockdown
of the protein was shown to increase nuclear accumula-
tion and phosphorylation of Smad2. This involvement
with Smad2 is of specific interest, as this gene and others
in the TGFb pathway have previously been highlighted
as candidate susceptibility genes for OM within the
WAFSOM cohort [9]. Furthermore, a GWAS carried out
in the Raine Study highlighted at least five other members
of the TGFb pathway (BMP5, GALNT13, NELL1, TGFB3
and BPIFA1) as candidates for OM susceptibility [11].
The strongest signal for association in our study lay
within the intergenic region between the TCERG1L and
PPP2R2D genes. Many association signals in complex
diseases have been found to lie within intergenic regions
[40], leading to a search for potential regulatory functions
within those regions. Whilst the top SNP (rs7922424) in
the intergenic region does not itself lie within a conserved
non-coding region, it is in strong LD with rs7087384 and
rs7914323, which do lie in highly conserved non-coding
regions. In addition, the minor disease associated alleles at
rs7922424 and rs7914323 alter putative binding sites for
the upstream stimulatory factor 1 (USF1). The USF1
transcription factor is a member of the helix-loop-helix
leucine zipper family and is ubiquitously expressed in a
variety of cells [53]. The role of this protein is wide-
spread, ranging from roles in embryonic development
[54] to promoters for a number of activity-induced genes
within neuronal nuclei [55] and as transcription factors
that regulate cell-type dependent cellular proliferation
[56]. However, our data favours rs7914323 as the most
likely regulatory polymorphism in this region. Not only
does this SNP lie within a conserved, non-coding region
that could harbor regulatory elements, but our analysis
shows that the presence of the minor allele potentially
eliminates a TFBS for the cAMP response element bind-
ing (CREB) transcription factor and its binding protein
(CREBP or CBP). This is interesting in the context of OM
as the function of CBP has been linked to the TGFb
pathway via the recruitment of EVI1 [57], which is mu-
tated in a mouse model of OM [58], although the EVI1
gene has not been associated with human susceptibility
to OM to date [9,59].
Overall, analysis of conserved, non-coding regions and
putative TFBS sites indicate a number of regulatory ele-
ments that lie within this intergenic region that can poten-
tially be influenced by polymorphisms associated with OM
susceptibility. It is not possible to determine from these
data which gene these regulatory elements may influence.
However, the TFBS consensus sequences disrupted by these
polymorphisms all lie on the forward strand, upstream of
the PPP2R2D promoter. The TCERG1L gene on the other
hand is encoded on the reverse strand. Taken together
these observations strengthen the evidence for PPP2R2D
as the likely gene contributing to linkage at 10q26.3.
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Using the resources available within the family-based
WAFSOM cohort the results of our study provide the
first replication of linkage to OM susceptibility at
chromosome 10q26.3. Subsequent association analysis
using data available within the longitudinal Raine Study
show that multiple genes could contribute to this linkage
peak, however the weight of evidence supports PPP2R2D
as the more likely functional candidate in this linkage
region. It has previously been noted that there is pheno-
typic heterogeneity between WAFSOM and the Raine
Study [11]. The phenotype defined for the Raine Study is
biased towards the milder end of the OM spectrum,
being based on yearly clinical examinations and parental
reports of ≥3 AOM episodes during the first three years
of life. The WAFSOM cohort on the other hand is
biased towards the more severe end of the OM
spectrum, being based on children recommended for
grommet insertion. This suggests that PPP2R2D plays a
role in susceptibility to OM per se. In summary our
results point to a role for PPP2R2D, a TGF-β/Activin/
Nodal pathway modulator, as the more likely functional
candidate for OM susceptibility at chromosome 10q26.3.
This contributes to the growing evidence for a role for
the TGFb pathway in susceptibility to this important
childhood disease.Additional files
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